Chemours (CC) Tops Q3 EPS by 4c

Chemours (NYSE: CC) reported Q3 EPS of $1.08, $0.04 better than the analyst estimate of $1.04. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.59 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Morgan Stanley Resumes Global Payments (GPN) at Equalweight
• AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion